CapaccioliS., QuattroneA., SchiavoneN., CalastrettiA., CopreniE., BevilacquaA., CantiG., GongL., Morelli5, NicolinA.: A bel2/IgH antisense transcript deregulates bcl2 gene expression in human follicular lymphoma t(14;18) cell lines.Oncogene, 13: 105–115, 1996.
2.
MorelliS., DeliaD., CapaccioliS., QuattroneA., SchiavoneN., BevilacquaA., Tomasini5, NicolinA.: The antisense bcl-2-IgH transcript is an optimal target for synthetic oligonucleotides.Proc Natl Acad Sci USA, 94: 8150–8155, 1997.
3.
SilvestriniR., VeneroniS., DaidoneM.G., BeniniP., BoracchiP., MezzettiM., Di FronzoG., RilkeF., VeronesiU.: The bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph nodenegative breast cancer patients.J Natl Cancer Inst, 86: 499–504, 1994.
SchiavoneN., RosiniP., QuattroneA., DonniniM., LapucciA., CittiL., BevilacquaA., NicolinA., CapaccioliS.: A conserved AUrich element in the 3’ untranslated region of bcl-2 mRNA is endowed with a destabilizing function that is involved in bcl-2 downregulation during apoptosis.FASEB J, 14: 174–184, 2000.
6.
RossJ.: Messenger RNA turnover in cellfree extracts from higher eukaryotes.Methods Mol Biol, 118: 459–476, 1999.
7.
BrewerG.: Characterization of cmyc 3′ to 5′ mRNA decay activities in an in vitro system.J Biol Chem, 273: 34770–34774, 1998.
